NEW YORK ( TheStreet) -- InterMune (Nasdaq: ITMN) hit a new 52-week low Friday as it is currently trading at $11.69, below its previous 52-week low of $12.52 with 4.5 million shares traded as of 11:30 a.m. ET. Average volume has been 1.2 million shares over the past 30 days. InterMune has a market cap of $1.2 billion and is part of the health care sector and drugs industry. Shares are down 65% year to date as of the close of trading on Thursday. InterMune, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapies in pulmonology and fibrotic diseases. The company has a P/E ratio of 9.5, below the average drugs industry P/E ratio of 10.2 and below the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter